论文部分内容阅读
目的:探讨沐舒坦注射液辅助治疗婴幼儿支气管肺炎的疗效。方法:治疗组55例在综合常规治疗的基础上,加用沐舒坦注射液7.5 mg/次,2次/d,疗程5~7 d雾化吸入。对照组55例综合常规治疗的基础上,加用生理盐水+α糜蛋白酶5 mg超声雾化吸入,2次/d,疗程5~7 d。比较两组患儿的症状及体征。结果:治疗组应用沐舒坦注射液辅助治疗婴幼儿支气管肺炎在咳嗽、痰鸣消失天数及罗音消失时间、住院天数均较对照组明显缩短。结论:沐舒坦注射液辅助治疗婴幼儿支气管肺炎,可缩短住院天数,迅速改善症状,明显提高疗效,尤其祛痰和减少肺部湿性罗音的效果较好。
Objective: To investigate the curative effect of mucosolvan injection in the treatment of infantile bronchopneumonia. Methods: 55 cases in the treatment group were treated with inhalation of mucosolvan by 7.5 mg / time for 2 times daily for 5-7 days on the basis of general treatment. The control group of 55 patients on the basis of general treatment, plus saline plus α 5 mg ultrasound inhalation, 2 times / d, treatment of 5 ~ 7 d. The symptoms and signs of children in two groups were compared. Results: In the treatment group, the treatment of infantile bronchopneumonia with mucosolvan injection was significantly shorter than the control group in the days of cough and phlegm disappearance, the disappearance of rales and the disappearance of rales. Conclusion: Ambroxol injection adjuvant treatment of infantile bronchopneumonia, can shorten the length of hospital stay, rapid improvement of symptoms, significantly improve the efficacy, especially expectorant and reduce lung wet rales sound better.